top of page
Opportunistic Bone Mineral Density (BMD) Screening
With FDA-Approved AI-Enabled AutoBMD™
No Extra Radiation, No Capital Equipment
Applicable to New and Existing CT Scans
“HeartLung is focused on AI-enabled early detection of subclinical preventable diseases such as coronary artery disease, lung cancer, osteoporosis, and fatty liver disease using CT scans which are available worldwide. AutoBMD™ is the first low-hanging fruit that we aimed and received FDA approval for. AutoCAC™ AutoLung™ and more will follow.”
Dr. Morteza Naghavi
Physician Inventor and Founder of HeartLung Technologies
President of SHAPE (Society for Heart Attack Prevention and Eradication)
bottom of page